medigraphic.com
ISSN 1561-3070 (Electronic)

2018, Number 2

<< Back Next >>

Rev Cub Oftal 2018; 31 (2)

Patient factors associated to ocular hypertension after uncomplicated phacoemulsification

Cuan AY, Da Silva RRO, Montero DE, Hormigó PIF, Pérez CEC, Cárdenas DT

Language: Spanish
References: 35
Page: 1-11
PDF size: 106.99 Kb.


ABSTRACT

Objective: identify the patient factors associated to an increase in intraocular pressure in the immediate postoperative period of uncomplicated phacoemulsification.
Methods: an observational retrospective correlational-descriptive study was conducted of a series of 131 patients undergoing cataract surgery by phacoemulsification technique at the Center for Ocular Microsurgery of Ramón Pando Ferrer Cuban Institute of Ophthalmology. The patients were divided into two groups based on intraocular pressure values: a group with postoperative ocular hypertension (Group OHT= 32), and the other without ocular hypertension after phacoemulsification (Group No OHT=99). Data on the study variables were obtained from the medical records of the patients making up the two groups. These variables were analyzed and statistically compared among themselves.
Results: age and sex did not differ statistically between the two study groups. Nonwhite skin color (p= 0.023) and the highest preoperative intraocular pressure values (p= 0.00) were associated to ocular hypertension after phacoemulsification. No association was found with preoperative personal pathological antecedents, ocular biometric parameters or the corneal endothelium of patients in the two groups.
Conclusions: Non-white skin color and higher preoperative intraocular pressure values are the patient factors associated to ocular hypertension after uncomplicated phacoemulsification.


REFERENCES

  1. Chatziralli IP. First postoperative day review after uneventful phacoemulsification cataract surgery: Is it necessary? BMC Research Notes. 2012;5:333.

  2. Poley BJ, Lindstrom RL, Samuelson TW, Schulze R. Intraocular pressure reduction after phacoemulsification with intraocular lens implantation in glaucomatous and nonglaucomatous eyes. J Cataract Refract Surg. 2009;35:1946-55.

  3. Koopman S. Cataract Surgery Devices-Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017. London, UK: Global Data; 2012 [cited March 18, 2014]. Available in: https://www.asdreports.com/shopexd.asp?id=25116

  4. Hernández JR. Técnica de facoemulsificación y sus variantes de corte mecánico previo del núcleo cataratoso: Resultados obtenidos. Tesis presentada en opción del grado de Doctor en Ciencias Médicas. Universidad Médica de La Habana; Cuba; 2009.

  5. Chang TC. Long-term effect of phacoemulsification on intraocular pressure using phakic fellow eye as control. J Cataract Refract Surg. 2012;38(5):866-70.

  6. Kim JY. Increased IOP on the first postoperative day following resident performed cataract surgery. Eye. 2011;25:929-36.

  7. Henderson BA, Steinert RF, Eichenbaum DA, Heier JS. Complications of IOL Surgery. Saunders Elsevier; 2008.

  8. Ko YC. Factors related to corneal endothelial damage after phacoemulsification in eyes with occludable angles. J Cataract Refract Surg. 2008;34(1). pp. 46-51.

  9. Rainer M. Intraocular pressure rise after small incision cataract surgery. Br J Ophthalmol. 2001;85:139-42.

  10. Coban-Karatas M, Sizmaz S, Altan-Yaycioglu R, Canan H, Akova YA. Risk factors for intraocular pressure rise following phacoemulsification. Indian J Ophthalmol. 2013;61:115-8.

  11. Iniesta-Sánchez LD. Modificación del endotelio corneal secundario a cirugía de catarata. Rev Sanid Milit Mex. 2011;65(6):257-64.

  12. Fernández-Vigo EC, Macarro MA, Lorente BB, Bausili PM. Estudio comparativo: Microscopia endotelial central y periférica en pacientes con lente Acrysof Cachet® vs. población normal. Madrid: Bol Soc Oftalmol. 2011 [citado 12 de junio de 2018];(51). Disponible en: http://sociedadoftalmologicademadrid.com/revistas/revista- 2011/m2011-03.html

  13. Poley BJ, Lindstrom RL, Samuelson TW. Long-term effects of phacoemulsification with intraocular lens implantation in normotensive and ocular hypertensive eyes. J Cataract Refract Surg. 2008;34(5):735-42.

  14. Mansberger SL. Reduction in intraocular pressure after cataract extraction: the ocular hypertension treatment study. Ophthalmology, 2012;119(9):1826-31.

  15. Villanueva-Nájera MA, Herrero-Herrera S. Resultados visuales en pacientes operados de facoemulsificación con implante de lente intraocular libre de microvacuolas en el Hospital General de México. Rev Mex Oftalmol. 2015;89(4):205-09.

  16. Gokhale PA, Patterson E. Elevated intraocular pressure after cataract surgery. In: Cataract surgery in the glaucoma patient. New York: Springer. 2009. pp. 51-5.

  17. Auffarth GU, Holzer MP, Vissesook N, Apple DJ, Volcker HE. Removal times and techniques of a viscoadaptive ophthalmic viscosurgical device. J Cataract Refract Surg. 2004;30:879-83.

  18. Mitani A. Evaluation of a new method of irrigation and aspiration for removal of ophthalmic viscoelastic device during cataract surgery in a porcine model. BMC Ophthalmol. 2014;14:129.

  19. Stephen A. Guidelines for the management of open angle glaucoma and ocular hypertension. In: American Academy of Ophthalmology. Glaucoma. San Francisco, CA: Basic and Clinical Science Course; 2014.

  20. Oshika T. Prospective randomized comparison of DisCoVisc and Healon5 in phacoemulsification and intraocular lens implantation. Eye. 2010;24:1376-81.

  21. American Academy of Ophthalmology. Lens and Cataract. San Francisco, CA: Basic and Clinical Science Course. 2014.

  22. Memarzadeh F, Ying-Lai M, Azen SP, Varma R. Associations with intraocular pressure in Latinos: Los Angeles Latino Eye Study. Am J Ophthalmol. 2008;146(1):69-76.

  23. Wu SY, Leske MC. Associations with intraocular pressure in the Barbados Eye Study. Arch Ophthalmol. 1997;115:1572-6.

  24. Klein BE, Klein R. Intraocular pressure and cardiovascular risk variables. Arch Ophthalmol. 1981;99:837-9.

  25. Shiose Y, Kawase Y. A new approach to stratified normal intraocular pressure in a general population. Am J Ophthalmol. 1986;101:714-21.

  26. Sommer A, Tielsch JM. Racial differences in the cause specific prevalence of blindness in east Baltimore. N Engl J Med. 1991;325:1412-7.

  27. Nannini D. African Ancestry is associated with higher intraocular pressure in Latinos. Ophthalmology. 2016;123(1):102-8.

  28. Hiller R, Sperduto RD, Krueger DE. Race, iris pigmentation and intraocular pressure. Am J Epidemiol. 1982;115:674-83.

  29. Mitchell R, Rochtchina E, Lee A. Iris color and intraocular pressure: the Blue Mountains Eye Study. Am J Ophthalmol. 2003;135:384-6.

  30. Hashemi H, Kashi AH, Fotouhi A, Mohammad K. Distribution of intraocular pressure in healthy Iranian individuals: the Teheran Eye Study. Br J Ophthalmol. 2005;89(6):652-7.

  31. Klein BE, Klein R, Linton KL. Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1992;33:2224-8.

  32. Wu SY, Leske MC. Associations with intraocular pressure in the Barbados Eye Study. Arch Ophthalmol. 1997;115:1572-6.

  33. Zhou M, Wang Wei, Huang W, Zhang X. Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. PLoS One. 2014;9(8):e102972.

  34. Quan XL , Ying HZ , Su J, Jun XH . Effects of phacoemulsification on intraocular pressure and anterior chamber depth. Exp Ther Med. 2013;5(2):507-10.

  35. O'Brien PD, Ho SL, Fitzpatrick P, Power W. Risk factors for a postoperative intraocular pressure spike after phacoemulsification. Canad J Ophthalmol. 2007;42(1):51-5.




2020     |     www.medigraphic.com